CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (4,688,000,000)	$ (1,018,000,000)	$ (426,000,000)
Depreciation and amortization	197,000,000	29,000,000	7,000,000
Stock-based compensation	570,000,000	0	0
Other expenses (Note 2)	643,000,000	0	0
Loss on convertible notes, net	441,000,000	0	0
Write-down of inventory	95,000,000	0	0
Other non-cash activities	36,000,000	41,000,000	37,000,000
Changes in operating assets and liabilities:
Accounts receivable	(20,000,000)	11,000,000	(16,000,000)
Inventory	(369,000,000)	0	0
Other current assets	(81,000,000)	(34,000,000)	(8,000,000)
Other non-current assets	(8,000,000)	(8,000,000)	(5,000,000)
Accounts payable and accrued liabilities	461,000,000	121,000,000	43,000,000
Customer deposits	46,000,000	10,000,000	14,000,000
Other current liabilities	37,000,000	1,000,000	15,000,000
Other non-current liabilities	18,000,000	(1,000,000)	(14,000,000)
Net cash used in operating activities	(2,622,000,000)	(848,000,000)	(353,000,000)
Cash flows from investing activities:
Capital expenditures	(1,794,000,000)	(914,000,000)	(199,000,000)
Net cash used in investing activities	(1,794,000,000)	(914,000,000)	(199,000,000)
Cash flows from financing activities:
Proceeds from share issuance upon initial public offering, net of underwriting discounts and commissions and offering costs	13,530,000,000	0	0
Proceeds from issuance of capital stock	2,658,000,000	2,506,000,000	2,750,000,000
Proceeds from issuance of convertible notes	2,500,000,000	0	0
Proceeds from issuance of long-term debt, net of discount and debt issuance costs	1,226,000,000	0	61,000,000
Principal payments and other financing activities	(86,000,000)	(6,000,000)	0
Net cash provided by financing activities	19,828,000,000	2,500,000,000	2,811,000,000
Net change in cash	15,412,000,000	738,000,000	2,259,000,000
Cash, cash equivalents, and restricted cash—Beginning of period	3,011,000,000	2,273,000,000	14,000,000
Cash, cash equivalents, and restricted cash—End of period	18,423,000,000	3,011,000,000	2,273,000,000
Supplemental disclosure of cash flow information:
Cash paid for interest	2,000,000	4,000,000	5,000,000
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	479,000,000	325,000,000	98,000,000
Conversion of convertible notes	2,941,000,000	0	100,000,000
Conversion of convertible preferred stock	7,894,000,000	0	0
Warrants issuance	$ 0	$ 3,000,000	$ 13,000,000